People who take weight-loss drugs based on GLP-1 receptor agonists seem to have reduced risk for a litany of diseases, including Alzheimer's, but an increase in some other conditions like kidney ...

John Navin is a freelance writer for Investopedia. His stock-trading work was profiled in "The Warren Buffetts Next Door: The World's Greatest Investors You've Never Heard Of." Samantha (Sam) ...